Stearidonic acid as a supplemental source of ω-3 polyunsaturated fatty acids to enhance status for improved human health

Nutrition

Volumn 29, Issue 2, 2013, Pages 363-369

  Walker, Celia G ^a   Jebb, Susan A ^a   Calder, Philip C ^b,c,d  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

3 Fatty acid metabolism; Biomarker; Eicosapentaenoic acid; Oil crops; Oily fish consumption

Indexed keywords

CHOLESTEROL; DOCOSAHEXAENOIC ACID; FATTY ACID ESTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; STEARIDONIC ACID; STEARIDONIC ACID ETHYL ESTER; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL FOOD; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; ERYTHROCYTE LEVEL; EVIDENCE BASED MEDICINE; FAT INTAKE; FATTY ACID BLOOD LEVEL; FISH; FOOD AVAILABILITY; FOOD COMPOSITION; FOOD CONTAMINATION; HEALTH STATUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; HYPOCHOLESTEROLEMIA; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; TASTE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WORLD HEALTH ORGANIZATION;

ALPHA-LINOLENIC ACID; ANIMALS; DIET; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FISHES; HUMANS; SEAFOOD;

EID: 84872262380     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.06.003     Document Type: Review

References (73)

1. Calder P.C. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 2004, 107:1-11.
2. Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Saito Y., Ishikawa Y., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
3. Marik P.E., Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 2009, 32:365-372.
4. Calder P.C. PUFA, inflammatory processes and rheumatoid arthritis. Proc Nutr Soc 2008, 67:409-418.
5. San Giovanni J.P., Parra-Cabrera S., Colditz G.A., Berkey C.S., Dwyer J.T. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 2000, 105:1292-1298.
6. Foster R., Williamson C.S., Lunn J. Briefing paper: culinary oils and their health effects. Nutr Bull 2009, 34:4-47.
7. Advice on fish consumption: benefits & risks 2004, Scientific Advisory Committee on Nutrition (SACN) and Committee on Toxicity (COT), Her Majesty's Stationery Office, London.
8. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757. for the Nutrition C.
9. Burdge G.C., Jones A.E., Wootton S.A. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 2002, 88:355-363.
10. Burdge G.C., Wootton S.A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002, 88:411-420.
11. Vidgren H., Ågren J., Schwab U., Rissanen T., Hänninen O., Uusitupa M. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 1997, 32:697-705.
12. Krul E.S., Lemke S.L., Mukherjea R., Taylor M.L., Goldstein D.A., Su H., et al. Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content. Prostaglandins Leukot Essent Fatty Acids 2012, 86:51-59.
13. James M.J., Ursin V.M., Cleland L.G. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr 2003, 77:1140-1145.
14. Mozaffarian D. Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr 2008, 87:1991S-1996S.
15. Strom M., Halldorsson T.I., Mortensen E.L., Torp-Pedersen C., Olsen S.F. Fish, n-3 fatty acids, and cardiovascular diseases in women of reproductive age. Hypertension 2012, 59:36-43.
16. Mozaffarian D., Lemaitre R.N., Kuller L.H., Burke G.L., Tracy R.P., Siscovick D.S. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003, 107:1372-1377.
17. He K., Song Y., Daviglus M.L., Liu K., Van Horn L., Dyer A.R., et al. Accumulated evidence on fish consumption and coronary heart disease mortality. Circulation 2004, 109:2705-2711.
18. Iso H., Kobayashi M., Ishihara J., Sasaki S., Okada K., Kita Y., et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese. Circulation 2006, 113:195-202.
19. Siscovick D.S., Raghunathan T.E., King I., Weinmann S., Wicklund K.G., Albright J., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363-1367.
20. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health. JAMA 2006, 296:1885-1899.
21. Leon H., Shibata M.C., Sivakumaran S., Dorgan M., Chatterley T., Tsuyuki R.T. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 2008, 337:a2931.
22. Musa-Veloso K., Binns M., Kocenas A., Poon T., Elliot J., Rice H., et al. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. Nutr Rev 2010, 68:155-167.
23. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition, and Allergies (NDA) Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J 2010, 8:1461.
24. Folsom A.R., Demissie Z. Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women. Am J Epidemiol 2004, 160:1005-1010.
25. Kromhout D., Giltay E.J., Geleijnse J.M. n-3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010, 363:2015-2026.
26. Bresson J.-L., Flynn A., Heinonen M., Hulshof K., Korhonen H., Lagiou P., et al. Scientific opinion: labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids. Scientific opinion of the panel on dietetic products, nutrition and allergies on a request from the commission related to labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids (question no EFSA-Q-2009-00548). EFSA J 2009, 1176:1-11.
27. Deckelbaum R., Torrejon C. The omega-3 fatty acid nutritional landscape: health benefits and sources. J Nutr 2012, 142:587S-591S.
28. Department of Health and the Food Standards Agency National diet and nutrition survey headline results from years 1 and 2 (combined) of the Rolling Programme (2008/2009-2009/10) 2011, Department of Health, London.
29. Jensen K.N., Jacobsen C., Nielsen H.H. Fatty acid composition of herring (Clupea harengus L.): influence of time and place of catch on n-3 PUFA content. J Sci Food Agric 2007, 87:710-718.
30. Moffat C., McGill A. Variability of the composition of fish oils: significance for the diet. Proc Nutr Soc 1993, 52:441-456.
31. Ministry of Agriculture, Fisheries and Food Fatty acids supplement to McCance and Widdowson's the composition of foods 1988, Royal Society of Chemistry, London.
32. Kris-Etherton P.M., Harris W.S., Appel L.J. AHA scientific statement: fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757. Nutrition C.
33. Hamilton M., Hites R., Schwager S., Foran J., Knuth B., Carpenter D. Lipid composition and contaminants in farmed and wild salmon. Environ Sci Technol 2005, 39:8622-8629.
34. Meyer B., Mann N., Lewis J., Milligan G., Sinclair A., Howe P. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003, 38:391-398.
35. Kennedy E.T., Luo H., Ausman L.M. Cost implications of alternative sources of (n-3) fatty acid consumption in the United States. J Nutr 2012, 142:605S-609S.
36. Seafood Choices Alliance. Constant cravings: the European consumer and sustainable seafood choices. 2005. Available at: Accessed December 15, 2011. http://www.seafoodchoices.org/resources/documents/EUConsumer.pdf.
37. Food and Agriculture Organization of the United Nations The state of world fisheries and aquaculture 2006 2007, FAO Fisheries and Aquaculture Department, Rome.
38. Joint Marine Programme. Feeding the fish: sustainable fish feed and Scottish aquaculture report: 199-UK/R/01/B. Hampshire: Poseidon Aquatic Resource Management; 2004.
39. Codabaccus M.B., Bridle A.R., Nichols P.D., Carter C.G. Effect of feeding Atlantic salmon (Salmo salar L.) a diet enriched with stearidonic acid from parr to smolt on growth and n-3 long-chain PUFA biosynthesis. Br J Nutr 2011, 105:1772-1782.
40. Blanchet C., Lucas M., Julien P., Morin R., Gingras S., Dewailly E. Fatty acid composition of wild and farmed Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss). Lipids 2005, 40:529-531.
41. UK Food Standards Agency. Fish Sustainability. Available at: Accessed December 15, 2011. http://www.food.gov.uk/foodindustry/farmingfood/fish/.
42. Williams C.M., Burdge G.C. Long-chain n-3 PUFA: plant v. marine sources. Proc Nutr Soc 2006, 65:42-50.
43. Burdge G.C., Calder P.C. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005, 45:581-597.
44. Horrobin D.F. Fatty acid metabolism in health and disease: the role of delta-6-desaturase. Am J Clin Nutr 1993, 57:732S-736S.
45. Merino D.M., Johnston H., Clarke S., Roke K., Nielsen D., Badawi A., et al. Polymorphisms in FADS1 and FADS2 alter desaturase activity in young Caucasian and Asian adults. Mol Genet Metab 2011, 103:171-178.
46. Das U.N. A defect in the activity of [Delta]6 and [Delta]5 desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007, 76:251-268.
47. Gurr M.I., Harwood J.L., Frayn K.N. Lipid biochemistry 2005, Blackwell Science, Oxford.
48. Guil-Guerrero J.L. Stearidonic acid: metabolism, nutritional importance, medical uses and natural sources. Eur J Lipid Sci Technol 2007, 109:1226-1236.
49. Harris W.S. Stearidonic acid-enhanced soybean oil: a plant-based source of (n-3) fatty acids for foods. J Nutr 2012, 142:600S-604S.
50. Bentley S. Corn gromwell: a new oil crop for UK farmers, containing stearidonic acid (SDA), an omega-3 fatty acid from plants with the health benefit of fish oils. Available at: Accessed December 15, 2011. http://www.niab.com/pages/id/319/Corn_Gromwell.
51. Kitessa S.M., Young P. Echium oil is better than rapeseed oil in enriching poultry meat with n-3 polyunsaturated fatty acids, including eicosapentaenoic acid and docosapentaenoic acid. Br J Nutr 2009, 101:709-715.
52. Rymer C., Hartnell G., Givens D. The effect of feeding modified soyabean oil enriched with C18: 4 n-3 to broilers on the deposition of n-3 fatty acids in chicken meat. Br J Nutr 2011, 105:866-878.
53. Kitessa S.M., Young P., Nattrass G., Gardner G., Pearce K., Pethick D.W. When balanced for precursor fatty acid supply echium oil is not superior to linseed oil in enriching lamb tissues with long-chain n-3 PUFA. Br J Nutr 2012, 108:71-79.
54. Bernal-Santos G., O'Donnell A., Vicini J., Hartnell G., Bauman D. Hot topic: Enhancing omega-3 fatty acids in milk fat of dairy cows by using stearidonic acid-enriched soybean oil from genetically modified soybeans. J Dairy Sci 2010, 93:32-37.
55. Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006, 83:S1467-S1476.
56. Goyens P.L.L., Spilker M.E., Zock P.L., Katan M.B., Mensink R.P. Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 2006, 84:44-53.
57. Pawlosky R.J., Hibbeln J.R., Novotny J.A., Salem N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 2001, 42:1257-1265.
58. Pawlosky R.J., Hibbeln J.R., Lin Y., Salem N. n-3 Fatty acid metabolism in women. Br J Nutr 2003, 90:993-994.
59. Brenna J., Salem N.J., Sinclair A., Cunnane S. International Society for the Study of Fatty Acids and Lipids I. [alpha]-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009, 80:85-91.
60. Lemke S.L., Vicini J.L., Su H., Goldstein D.A., Nemeth M.A., Krul E.S., et al. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr 2010, 92:766-775.
61. Myint P.K., Welch A.A., Bingham S.A., Luben R.N., Wareham N.J., Day N.E., et al. Habitual fish consumption and risk of incident stroke: the European Prospective Investigation into Cancer (EPIC) Norfolk prospective population study. Public Health Nutr 2006, 9:882-888.
62. Miles E.A., Banerjee T., Dooper M.M.B.W., M'Rabet L., Graus Y.M.F., Calder P.C. The influence of different combinations of gamma-linolenic acid, stearidonic acid and EPA on immune function in healthy young male subjects. Br J Nutr 2004, 91:893-903.
63. Yamazaki K., Fujikawa M., Hamazaki T., Yano S., Shono T. Comparison of the conversion rates of [alpha]-linolenic acid (18:3(n-3)) and stearidonic acid (18:4(n-3)) to longer polyunsaturated fatty acids in rats. Biochim Biophys Acta 1992, 1123:18-26.
64. Gregory M.K., Gibson R.A., Cook-Johnson R.J., Cleland L.G., James M.J. Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis. PLoS One 2011, 6:e29662.
65. Harris W., Lemke S., Hansen S., Goldstein D., DiRienzo M., Su H., et al. Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker. Lipids 2008, 43:805-811.
66. Itakura H., Yokoyama M., Matsuzaki M., Saito Y., Origasa H., Ishikawa Y., et al. Relationships between plasma fatty acid composition and coronary artery disease. J Atheroscler Thromb 2011, 18:99-107.
67. von Schacky C. A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vasc Health Risk Manag 2006, 2:251-262.
68. Lee S., Shin M., Kim J., Ko Y., Kang S., Choi D., et al. Blood eicosapentaenoic acid and docosahexaenoic acid as predictors of all-cause mortality in patients with acute myocardial infarction-data from Infarction Prognosis Study (IPS) Registry. Circ J 2009, 73:2250-2257.
69. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.E., Willett W.C., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346:1113-1118.
70. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., Best J.D., et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000, 71:1085-1094.
71. Cottin S.C., Sanders T.A., Hall W.L. The differential effects of EPA and DHA on cardiovascular risk factors. Proc Nutr Soc 2011, 70:215-231.
72. Mori T., Woodman R. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 2006, 9:95-104.
73. Surette M.E., Edens M., Chilton F.H., Tramposch K.M. Dietary echium oil increases plasma and neutrophil long-chain (n-3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans. J Nutr 2004, 134:1406-1411.